2021 tables: Institutions - life sciences - corporate

The 2021 tables are based on Nature Index data from 1 January 2020 to 31 December 2020.

Table criteria

# Institution Share 2019 Share 2020 Count 2020 Change in Adjusted Share 2019-2020*
1 BGI, China 9.12 7.50 51 -24.4%
2 Formosa Plastics Group, Taiwan 3.59 5.93 25 51.8%
3 Samsung Group, South Korea 2.55 2.43 29 -12.4%
4 Takeda Pharmaceutical Company Limited, Japan 3.11 2.16 14 -36.3%
5 Nippon Telegraph and Telephone Corporation (NTT), Japan 1.56 2.00 2 18.1%
6 China National Chemical Corporation (ChemChina), China 1.79 1.59 6 -18.4%
7 Advanced Telecommunications Research Institute International (ATR), Japan 1.08 1.31 4 12.1%
8 Kao Corporation, Japan 0.14 1.25 4 705.3%
9 The New Zealand Institute for Plant and Food Research Ltd., New Zealand 1.19 1.17 15 -9.6%
10 Otsuka Holdings Co., Ltd., Japan 1.18 1.08 6 -15.6%
11 Astellas Pharma Inc., Japan 0.01 0.97 5 7,678.5%
12 Seikagaku Corporation, Japan 0.95 2 N/A
13 Cellivery, South Korea 0.89 1 N/A
14 Wilmar International Limited, Singapore 0.88 1 N/A
15 EnGeneIC Ltd., Australia 0.85 1 N/A
16 Novogene Co., Ltd., China 0.34 0.84 12 125.5%
17 Daiichi Sankyo Co., Ltd., Japan 1.63 0.80 6 -54.9%
18 China Shipbuilding Industry Corporation (CSIC), China 0.61 0.74 43 11.9%
19 Fosun Pharma, China 0.71 1 N/A
20 China National Pharmaceutical Group (Sinopharm), China 0.70 2 N/A
21 JT Biohistory Research Hall (BRH), Japan 0.64 2 N/A
22 Topchoice Group, China 0.85 0.64 10 -31.4%
23 GrandOmics Biosciences, China 0.30 0.61 2 83.9%
24 Tencent, China 0.20 0.60 3 177.9%
25 Takii and Company, Limited, Japan 0.56 1 N/A
26 Sony Corporation, Japan 0.51 0.52 2 -6.1%
27 AmorePacific Corporation, South Korea 0.50 1 N/A
28 Mabwell (Shanghai) Bioscience Co., Ltd., China 0.48 1 N/A
29 Singlera Genomics Inc., China 0.05 0.47 1 718.2%
29 Zhejiang NHU Company Ltd., China 0.47 1 N/A
30 WuXi AppTec, China 0.58 0.45 9 -28.3%
31 Ajinomoto Co., Inc., Japan 0.01 0.45 4 3,475.7%
32 Sinovac Biotech Co., Ltd., China 0.09 0.44 1 345.8%
33 Institute of Environmental Science and Research (ESR), New Zealand 0.40 1 N/A
34 Beijing Solidwill Sci-Tech Co., Ltd., China 0.38 1 N/A
35 Metabolomics Australia (MA), Australia 0.35 0.38 5 -0.4%
36 Doctor's Choice Co., Ltd., Japan 0.38 1 N/A
37 FiberHome Technologies Group, China 0.39 0.37 12 -14.0%
38 Tata Group, India 0.35 2 N/A
39 Shimadzu Corporation, Japan 0.14 0.35 4 123.8%
40 Kowa Company, Ltd., Japan 0.24 0.35 4 33.7%
41 Clinomics Inc., South Korea 0.35 2 N/A
42 Kansai Electric Power Co., Inc., Japan 0.14 0.35 5 133.1%
43 National Vaccine and Serum Institute, China 0.34 1 N/A
44 Amine Pharma Research Institute Co., Ltd., Japan 0.34 2 N/A
45 Il Yang Pharmaceutical Co. Ltd., South Korea 0.33 1 N/A
45 Clarity Pharmaceuticals, Australia 0.33 1 N/A
46 Hamamatsu Photonics K.K., Japan 0.03 0.33 3 869.4%
47 Mynvax Private Limited, India 0.32 1 N/A
48 Theragen Etex Bio Institute, South Korea 0.02 0.32 2 1,124.9%
49 Scion, New Zealand 0.14 0.31 7 110.8%
50 Hangzhou Dixiang Import & Export Co. Ltd, China 0.31 1 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.